Generation of HLA-Universal iPSC-Derived Megakaryocytes and Platelets for Survival Under Refractoriness Conditions-Reference-Cited by-同舟云学术

Generation of HLA-Universal iPSC-Derived Megakaryocytes and Platelets for Survival Under Refractoriness Conditions

Published:2016-01 Issue:1 Volume:22 Page:274-285
ISSN:1076-1551
Container-title:Molecular Medicine
language:en
Short-container-title:Mol Med

Author:

Börger Ann-Kathrin,Eicke Dorothee,Wolf Christina,Gras Christiane,Aufderbeck Susanne,Schulze Kai,Engels Lena,Eiz-Vesper Britta,Schambach Axel,Guzman Carlos A,Lachmann Nico,Moritz Thomas,Martin Ulrich,Blasczyk Rainer,Figueiredo Constança

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Genetics,Molecular Biology,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.2119/molmed.2015.00235.pdf

Reference41 articles.

1. Fasano RM, et al. (2014) Persistence of recipient human leucocyte antigen (HLA) antibodies and production of donor HLA antibodies following reduced intensity allogeneic haematopoietic stem cell transplantation. Br. J. Haematol. 166:425–34. DOI 10.1111/bjh.12890

2. Stanworth SJ, Navarrete C, Estcourt L, Marsh J. (2015) Platelet refractoriness — practical approaches and ongoing dilemmas in patient management. Br. J. Haematol. 171:297–305. DOI 10.1111/bjh.13597

3. Rebulla P. (2005) A mini-review on platelet refractoriness. Haematologica. 90:247–53.

4. Pena JR. (2014) Anti-HLA alloantibodies in surgical patients refractory to platelet transfusion. Am. J. Hematol. 89:E133–E137. DOI 10.1002/ajh.23757

5. Beligaswatte A. (2013) The mean fluorescence intensities of anti-HLA antibodies detected using micro-bead flow cytometry predict the risk of platelet transfusion refractoriness. Br. J. Haematol. 162:409–12. DOI 10.1111/bjh.12369

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Knockdown of swine leukocyte antigen expression in porcine lung transplants enables graft survival without immunosuppression;Science Translational Medicine;2024-07-17

2. Generation of hypoimmunogenic universal iPSCs through HLA-type gene knockout;2024-07-03

3. Heart immunoengineering by lentiviral vector-mediated genetic modification during normothermic ex vivo perfusion;Frontiers in Immunology;2024-06-05

4. Mesenchymal stem cells for cartilage regeneration: Insights into molecular mechanism and therapeutic strategies;Tissue and Cell;2024-06

5. CRISPR-Cas9 immune-evasive hESCs are rejected following transplantation into immunocompetent mice;Frontiers in Genome Editing;2024-05-28